Hospital
Astera Health
Astera Health was paid $3.72M by Medicaid between Jan 2018 and Nov 2024, across 66 billing codes. Its largest line is 99283, emergency room visit (moderate) — 31% of everything it billed.
33Billing provider infoASTERA HEALTH
WADENA, MN 56482
WADENA, MN 56482
33aNPI1477545333assigned 08/17/2005
33bProvider typeCritical Access Hospital
28Total paid$3.72M
24GClaims73,682
24DCodes billed66
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Minnesota
Rank by total paid#9 of 68
Median peer was paid$798K
This provider vs. median4.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,696 | $170K | |
| 2019 | 12,655 | $652K | |
| 2020 | 8,937 | $351K | |
| 2021 | 11,379 | $471K | |
| 2022 | 12,453 | $627K | |
| 2023 | 16,519 | $938K | |
| 2024incomplete | 7,043 | $516K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 31% | 10,466 | 8,791 | $1.14M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 3,131 | 2,469 | $458K |
| 36415 | Collection of venous blood by venipuncture | 11% | 18,365 | 15,972 | $399K |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 5.0% | 457 | 398 | $185K |
| 80053 | Comprehensive metabolic panel | 4.9% | 5,060 | 4,653 | $183K |
| A0425 | Ground mileage, per statute mile | 4.6% | 867 | 725 | $170K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.2% | 3,529 | 3,426 | $155K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.0% | 8,941 | 7,940 | $150K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.1% | 1,759 | 1,583 | $116K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.0% | 2,374 | 2,317 | $111K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.8% | 1,335 | 494 | $103K |
| J3490 | Unclassified drugs | 2.5% | 5,538 | 2,757 | $92K |
54 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.4% | 1,069 | $89K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 1,110 | $43K |
| 87631 | 1.1% | 259 | $42K | |
| 84484 | <1% | 528 | $32K | |
| 83735 | <1% | 1,127 | $28K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 753 | $23K |
| 86140 | <1% | 1,192 | $16K | |
| 99285 | Emergency room visit (most serious) | <1% | 73 | $15K |
| 71045 | Radiologic examination, chest; single view | <1% | 561 | $15K |
| 83880 | <1% | 230 | $14K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 128 | $12K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 855 | $12K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 145 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 416 | $10K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 91 | $9K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 150 | $7K |
| 83605 | <1% | 291 | $7K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 44 | $6K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 42 | $6K |
| 85730 | <1% | 248 | $6K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 180 | $6K |
| J2704 | Injection, propofol, 10 mg | <1% | 188 | $5K |
| 80061 | Lipid panel | <1% | 178 | $5K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 26 | $5K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 197 | $4K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 145 | $4K |
| 87070 | <1% | 227 | $4K | |
| 82553 | <1% | 77 | $3K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 86 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 100 | $3K |
| 85610 | <1% | 280 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 91 | $2K |
| 81001 | <1% | 115 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 97 | $1K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 61 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 64 | $1K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 31 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 40 | $907.93 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 31 | $859.13 |
| 83690 | <1% | 26 | $651.00 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 40 | $577.41 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 31 | $466.23 |
| 85027 | <1% | 28 | $462.48 | |
| 73110 | <1% | 16 | $403.58 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 25 | $377.68 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 13 | $374.40 |
| 84145 | <1% | 12 | $347.56 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 12 | $242.41 |
| 85379 | <1% | 14 | $220.63 | |
| 80069 | <1% | 15 | $214.24 | |
| 81003 | <1% | 14 | $119.81 | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | <1% | 14 | $43.73 |
| A6404 | Gauze, non-impregnated, sterile, pad size more than 48 sq. in., without adhesive border, each dressing | <1% | 14 | $2.39 |
| 99213 | Doctor's office visit, returning patient (routine) | 0% | 60 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBEISWENGER, JOEL (CEO)
| Provider | Location | Paid |
|---|---|---|
| Astera Health | Wadena, MN | $22.03M |
| Astera Health | Henning, MN | $864K |
| Astera Health | Sebeka, MN | $428K |
| Astera Health | Ottertail, MN | $408K |
| Astera Health | Bertha, MN | $401K |
| Astera Health | Verndale, MN | $104K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.